Kang Xu

Kang Xu

Auto-generated profile, based on publicly available information

Kang Xu

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
YCYu Chen
Yu Chen
LWLiang Wang
Liang Wang
WHWen-Tao Hou
Wen-Tao Hou
ZZZhi-Hui Zha
Zhi-Hui Zha
KXKang Xu
Kang Xu
YCYuxing Chen
Yuxing Chen
The activation and accumulation of human platelets contributes to hemostasis and thrombosis, the imbalance of which would cause cardiovascular diseases, an increasing threat to the global health. Human ABC transporter ABCC4 that pumps out the platelet agonist and anti-platelet drug such as aspirin, might become a promising target for preventing cardiovascular diseases. Here we solve the structures of human ABCC4 in the apo and two complexed forms, all of which adopt a typical architecture of type-IV ABC transporters in an inward-facing conformation. Structure of ABCC4 complexed with U46619, an analog of the unstable TXA 2 , provides the first structural evidence that the platelet agonist TXA 2 is also exported via ABCC4. The dipyridamole-complexed structure reveals the inhibitory mechanism of dipyridamole against ABCC4. Structural comparisons enabled us to identify a transmembrane pocket in ABCC4 that provides a defined space for the rational design of specific anti-platelet drugs.